Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication July 12, 2020
- Accepted for publication September 9, 2020
- Published online November 2, 2020.
Article Versions
- previous version (October 9, 2020 - 13:53).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2020 by the Society of Nuclear Medicine and Molecular Imaging. Immediate Open Access: Creative Commons Attribution 4.0 International License (CC BY) allows users to share and adapt with attribution, excluding materials credited to previous publications. License: https://creativecommons.org/licenses/by/4.0/. Details: http://jnm.snmjournals.org/site/misc/permission.xhtml.
Author Information
- Tiffany G. Chan,
- Edward O’Neill,
- Christine Habjan and
- Bart Cornelissen
- For correspondence or reprints contact: Bart Cornelissen, Department of Oncology, MRC Oxford Institute for Radiation Oncology, University of Oxford, Old Road Campus Research Building, Oxford, OX3 7LJ, United Kingdom. E-mail: bart.cornelissen{at}oncology.ox.ac.uk
Statistics from Altmetric.com
Cited By...
Article usage
Jump to section
- Article
- Abstract
- INCREASING DNA DAMAGE WITH TRADITIONAL CHEMOTHERAPIES
- RADIOSENSITIZATION THROUGH INHIBITING DNA REPAIR
- RADIOSENSITIZATION THROUGH INHIBITING PHOSPHOINOSITIDE-3-KINASE/PROTEIN KINASE B/MAMMALIAN TARGET OF RAPAMYCIN (MTOR) SIGNALING
- RADIOSENSITIZATION THROUGH INHIBITING HEDGEHOG SIGNALING
- RADIOSENSITIZATION THROUGH INHIBITING P53–MURINE DOUBLE MINUTE 2 (MDM2) INTERACTIONS
- RADIOSENSITIZATION THROUGH DISRUPTING CELL CYCLE
- RADIOSENSITIZATION THROUGH DISRUPTING NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD+) METABOLISM
- RADIOSENSITIZATION THROUGH BLOCKING IMMUNE CHECKPOINTS
- OUTLOOK
- DISCLOSURE
- Footnotes
- REFERENCES
- Figures & Data
- Info & Metrics
Related Articles
Cited By...
- No citing articles found.